Lab Reagents
Az Laboratories manufactures the az ige orzoi: tanulmanyok reagents distributed by Genprice. The Az Ige Orzoi: Tanulmanyok reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Az. Other Az products are available in stock. Specificity: Az Category: Ige Group: Orzoi: Tanulmanyok
Orzoi: Tanulmanyok information
AZ 628 |
|
A8371-25 |
ApexBio |
25 mg |
EUR 366 |
|
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase. |
AZ 628 |
|
A8371-5 |
ApexBio |
5 mg |
EUR 157.2 |
|
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase. |
AZ 628 |
|
A8371-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 166.8 |
|
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase. |
AZ 628 |
|
A8371-50 |
ApexBio |
50 mg |
EUR 560.4 |
|
Description: AZ628 is a potent and newly discorvered inhibitor of BRAF, c-Raf-1 and BRAFV600E with IC50 values of 105 nM, 29 nM and 34 nM, respectively. This compound prevents CRAF activation through persistently occupying the ATP-binding site of Raf kinase. |
AZ 960 |
|
A4144-1 |
ApexBio |
1 mg |
EUR 217.2 |
|
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members |
AZ 960 |
|
A4144-10 |
ApexBio |
10 mg |
EUR 932.4 |
|
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members |
AZ 960 |
|
A4144-5 |
ApexBio |
5 mg |
EUR 616.8 |
|
Description: AZ960 is a novel inhibitor of janus-associated kinases (JAKs) that exhibits a potent inhibition against janus kinase 2 (JAK2) with the value of inhibition constant of Ki of 0.45 nmol/L. It also exhibits a lesser inhibitory effects against other JAKs family members |
AZ 10417808 |
|
A4416-5 |
ApexBio |
5 mg |
EUR 459.6 |
|
Description: AZ 10417808 is a selective caspase-3 inhibitor with IC50 value of 14.9 uM [1].The caspase-3 protein is a member of the cysteine-aspartic acid protease (caspase) family. |
AZ 11645373 |
|
B7362-10 |
ApexBio |
10 mg |
EUR 439.2 |
|
Description: AZ11645373 is identified as a highly selective and potent antagonist of human P2X7 receptors but not mouse/rat P2X7 receptors. Adenosine 5?-triphosphate (ATP)-gated P2X receptors (P2XRs) comprise of seven genes which encode plasma membrane ion channels for calcium cation. |
AZ 11645373 |
|
B7362-50 |
ApexBio |
50 mg |
EUR 1654.8 |
|
Description: AZ11645373 is identified as a highly selective and potent antagonist of human P2X7 receptors but not mouse/rat P2X7 receptors. Adenosine 5?-triphosphate (ATP)-gated P2X receptors (P2XRs) comprise of seven genes which encode plasma membrane ion channels for calcium cation. |
